Presidential Symposium for NIAGARA will highlight practice-changing impact of a perioperative Imfinzi-based regimen in bladder cancer
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
The approval further adds to Biocon’s portfolio of complex drug products
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
Ordspono is Regeneron’s first approved bispecific antibody and will provide an off-the-shelf option that can be administered in the out-patient setting, with hope for complete remission
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
ZenBio is a highly regarded science-focused company specializing in biospecimens and related services with scientific expertise
Subscribe To Our Newsletter & Stay Updated
